HIV Research

Identification and development of broadly neutralizing monoclonal antibodies (mAbs) is an exciting avenue to explore as a tool to both prevent HIV infection and as a therapy in HIV cure strategies. This could be of particular importance to the U.S. military to improve the safety of the emergency blood supply.

MHRP is a leader in international efforts to develop an HIV vaccine. MHRP is advancing novel vaccine strategies and prevention products, and supporting the development of promising vaccine candidates.

MHRP's acute HIV infection (AHI) cohorts provide insight into critical early days after infection. These MHRP-led studies continue to expand the field’s knowledge of immune responses in acute infection, expose mechanisms for treatment and cure, and inform rational design of vaccines and other interventions.

MHRP's Department of Epidemiology and Threat Assessment conducts research on the epidemiology of HIV and other infectious diseases that threaten the readiness of U.S. and allied military forces. This research informs countermeasure development, and policy development and public health practices to decrease the rates of HIV and other STIs in the military.